From the score we can see that the expression level of CKIP-1 in glioma tissues is lower than that in normal brain tissues, and the activation level of AKT/GSK3β/β-catenin signaling pathway is significantly higher than that in normal brain tissues. The gene discussed is AKT1; the disease is central nervous system cancer.